Chemotherapy for small-cell lung cancer

H. Ueoka, Katsuyuki Kiura, Masahiro Tabata, A. Bessho, A. Matsushita, K. Chikamori, H. Yamane, M. Harada, I. Kimura, T. Ohnoshi

Research output: Contribution to journalArticle

Abstract

Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalJapanese Journal of Thoracic Diseases
Volume34
Issue numberSUPPL.
Publication statusPublished - 1996

Fingerprint

Small Cell Lung Carcinoma
irinotecan
Drug Therapy
Survival
Stem Cell Transplantation
Etoposide
Paclitaxel
Cisplatin
Thorax
Therapeutics
Pharmaceutical Preparations

Keywords

  • Chemotherapy
  • Dose-intensive chemotherapy
  • High-dose chemotherapy
  • Small-cell lung cancer
  • Thoracic irradiation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Ueoka, H., Kiura, K., Tabata, M., Bessho, A., Matsushita, A., Chikamori, K., ... Ohnoshi, T. (1996). Chemotherapy for small-cell lung cancer. Japanese Journal of Thoracic Diseases, 34(SUPPL.), 87-91.

Chemotherapy for small-cell lung cancer. / Ueoka, H.; Kiura, Katsuyuki; Tabata, Masahiro; Bessho, A.; Matsushita, A.; Chikamori, K.; Yamane, H.; Harada, M.; Kimura, I.; Ohnoshi, T.

In: Japanese Journal of Thoracic Diseases, Vol. 34, No. SUPPL., 1996, p. 87-91.

Research output: Contribution to journalArticle

Ueoka, H, Kiura, K, Tabata, M, Bessho, A, Matsushita, A, Chikamori, K, Yamane, H, Harada, M, Kimura, I & Ohnoshi, T 1996, 'Chemotherapy for small-cell lung cancer', Japanese Journal of Thoracic Diseases, vol. 34, no. SUPPL., pp. 87-91.
Ueoka H, Kiura K, Tabata M, Bessho A, Matsushita A, Chikamori K et al. Chemotherapy for small-cell lung cancer. Japanese Journal of Thoracic Diseases. 1996;34(SUPPL.):87-91.
Ueoka, H. ; Kiura, Katsuyuki ; Tabata, Masahiro ; Bessho, A. ; Matsushita, A. ; Chikamori, K. ; Yamane, H. ; Harada, M. ; Kimura, I. ; Ohnoshi, T. / Chemotherapy for small-cell lung cancer. In: Japanese Journal of Thoracic Diseases. 1996 ; Vol. 34, No. SUPPL. pp. 87-91.
@article{aeebb5416b5f4cab9329e93139d028a4,
title = "Chemotherapy for small-cell lung cancer",
abstract = "Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.",
keywords = "Chemotherapy, Dose-intensive chemotherapy, High-dose chemotherapy, Small-cell lung cancer, Thoracic irradiation",
author = "H. Ueoka and Katsuyuki Kiura and Masahiro Tabata and A. Bessho and A. Matsushita and K. Chikamori and H. Yamane and M. Harada and I. Kimura and T. Ohnoshi",
year = "1996",
language = "English",
volume = "34",
pages = "87--91",
journal = "Respiratory Investigation",
issn = "2212-5345",
publisher = "Elsevier BV",
number = "SUPPL.",

}

TY - JOUR

T1 - Chemotherapy for small-cell lung cancer

AU - Ueoka, H.

AU - Kiura, Katsuyuki

AU - Tabata, Masahiro

AU - Bessho, A.

AU - Matsushita, A.

AU - Chikamori, K.

AU - Yamane, H.

AU - Harada, M.

AU - Kimura, I.

AU - Ohnoshi, T.

PY - 1996

Y1 - 1996

N2 - Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

AB - Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

KW - Chemotherapy

KW - Dose-intensive chemotherapy

KW - High-dose chemotherapy

KW - Small-cell lung cancer

KW - Thoracic irradiation

UR - http://www.scopus.com/inward/record.url?scp=0030438360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030438360&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 87

EP - 91

JO - Respiratory Investigation

JF - Respiratory Investigation

SN - 2212-5345

IS - SUPPL.

ER -